[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

GB1453034A - Pharmaceutical composition for treating spasticity - Google Patents

Pharmaceutical composition for treating spasticity

Info

Publication number
GB1453034A
GB1453034A GB5808872A GB5808872A GB1453034A GB 1453034 A GB1453034 A GB 1453034A GB 5808872 A GB5808872 A GB 5808872A GB 5808872 A GB5808872 A GB 5808872A GB 1453034 A GB1453034 A GB 1453034A
Authority
GB
United Kingdom
Prior art keywords
hydroxy
dihydroxyphenyl
butylaminoethane
tert
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5808872A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CH Boehringer Sohn AG and Co KG
Boehringer Ingelheim GmbH
Original Assignee
CH Boehringer Sohn AG and Co KG
Boehringer Ingelheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CH Boehringer Sohn AG and Co KG, Boehringer Ingelheim GmbH filed Critical CH Boehringer Sohn AG and Co KG
Priority to GB5808872A priority Critical patent/GB1453034A/en
Priority to DE2362123A priority patent/DE2362123A1/en
Priority to IE2267/73A priority patent/IE38655B1/en
Priority to BE138890A priority patent/BE808662A/en
Priority to AU63647/73A priority patent/AU491048B2/en
Priority to IL43820A priority patent/IL43820A/en
Priority to ZA00739480*DA priority patent/ZA739480B/en
Publication of GB1453034A publication Critical patent/GB1453034A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

1453034 Skeletal muscle relaxing preparations BOEHRINGER INGELHEIM GmbH 14 Dec 1973 [15 Dec 1972] 58088/72 Heading A5B . A pharmaceutical composition for use in the treatment of spastically disabled human being comprises a sympathomimetic amine or a physiologically acceptable salt thereof together with an effective amount of sustained or delayed release agent, said amine being: 1-(3, 5-dihydroxyphenyl)-1 -hydroxy-2-isopropylaminoethane; 1-(4-amino-3, 5-dichlorophenyl) - 1 -hydroxy-2-tert-butylaminoethane; 1-(3-hydroxymethyl -4- hydroxyphenyl) -1- hydroxy -2- tert butylaminoethane; 1-(3, 5 - dihydroxyphenyl) -1- hydroxy -2- (1-(4-hydroxybenzyl) ethyl)-aminoethane; 1-(3, 5-dihydroxyphenyl)- 1 -hydroxy-2-tert butylaminoethane; N, N'-bis- [1-(3, 4-dihydroxyphenyl)-1-hydroxyethyl (2)]- hexamethylenediamine; 1-(3, 4-dihydroxyphenyl)-1 -hydroxy-2-isopropylaminoethane; 2-[(3, 4-dihydroxyphenyl) hydroxymethyl] piperidinium hydrobromide; 8-hydroxy-5-( 1 -hydroxy-2- isopropylaminoethyl) quinoline; 1-diphenylmethyl-4-hydroxyethoxyethyl-piperazine; 1 -phenethylpiperidine-4-spiro-5'-[1', 3']-oxazolidin-2'- one; and 1-(2-phenyl-2-methoxyethyl)-4-(3-hydroxy-3-phenylpropyl) piperazine. The composition may be in a form suitable for oral or parenteral administration.
GB5808872A 1972-12-15 1972-12-15 Pharmaceutical composition for treating spasticity Expired GB1453034A (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GB5808872A GB1453034A (en) 1972-12-15 1972-12-15 Pharmaceutical composition for treating spasticity
DE2362123A DE2362123A1 (en) 1972-12-15 1973-12-14 PHARMACEUTICAL PREPARATIONS
IE2267/73A IE38655B1 (en) 1972-12-15 1973-12-14 Pharmaceutical compositions for treating spasticity
BE138890A BE808662A (en) 1972-12-15 1973-12-14 SYMPATHOMIMETIC AMINE COMPOSITIONS
AU63647/73A AU491048B2 (en) 1972-12-15 1973-12-14 Chemical compositions
IL43820A IL43820A (en) 1972-12-15 1973-12-14 Pharmaceutical compositions for treatment of spastically disabled human beings containing bronchodilating sympathomimetic amines
ZA00739480*DA ZA739480B (en) 1972-12-15 1973-12-14 Improvements relating to compositions for treating spastic disablement

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5808872A GB1453034A (en) 1972-12-15 1972-12-15 Pharmaceutical composition for treating spasticity

Publications (1)

Publication Number Publication Date
GB1453034A true GB1453034A (en) 1976-10-20

Family

ID=10480743

Family Applications (1)

Application Number Title Priority Date Filing Date
GB5808872A Expired GB1453034A (en) 1972-12-15 1972-12-15 Pharmaceutical composition for treating spasticity

Country Status (6)

Country Link
BE (1) BE808662A (en)
DE (1) DE2362123A1 (en)
GB (1) GB1453034A (en)
IE (1) IE38655B1 (en)
IL (1) IL43820A (en)
ZA (1) ZA739480B (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0120165A2 (en) * 1982-12-10 1984-10-03 Greenway III, Frank L. A preparation and a process for achieving regional weight control
US4751071A (en) * 1983-12-01 1988-06-14 Alza Corporation Composition comprising salbutamol
US4777049A (en) * 1983-12-01 1988-10-11 Alza Corporation Constant release system with pulsed release
US4851229A (en) * 1983-12-01 1989-07-25 Alza Corporation Composition comprising a therapeutic agent and a modulating agent
AT390191B (en) * 1982-05-27 1990-03-26 Glaxo Group Ltd METHOD FOR PRODUCING LIQUID PHARMACEUTICAL COMPOSITIONS WITH A CONTENT OF 2-TERT.BUTYLAMINO-1- (4'-HYDROXY-3'HYDROXYMETHYLPHENYL) -ETHANOL (1)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1574894A (en) * 1977-06-02 1980-09-10 Nippon Kayaku Kk Derivative of a-methyl-aminopropiophenone and use thereof
DE2929456A1 (en) * 1979-07-20 1981-02-05 Lentia Gmbh COMPOSITION WITH EXTENDED BRONCHOLYTIC AND TOCOLYTIC EFFECTIVENESS, A METHOD FOR THE PRODUCTION THEREOF AND BRONCHOLYTIC AND TOKOLYTICALLY ACTIVE AGENT
US5310559A (en) * 1982-09-01 1994-05-10 Hercon Laboratories Corporation Device for controlled release and delivery to mammalian tissue of pharmacologically active agents incorporating a rate controlling member which comprises an alkylene-alkyl acrylate copolymer
US5468501A (en) * 1982-09-01 1995-11-21 Hercon Laboratories Corporation Article useful for administration of pharmacologically-active substances transdermally, orally or by means of implant
JPS6061523A (en) * 1983-09-16 1985-04-09 Shionogi & Co Ltd Oral dobutamine pharmaceutical
DE3786199T2 (en) * 1986-04-03 1993-09-23 Hercon Lab ARTICLES FOR THE ADMINISTRATION OF PHARMACOLOGICALLY ACTIVE SUBSTANCES.

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT390191B (en) * 1982-05-27 1990-03-26 Glaxo Group Ltd METHOD FOR PRODUCING LIQUID PHARMACEUTICAL COMPOSITIONS WITH A CONTENT OF 2-TERT.BUTYLAMINO-1- (4'-HYDROXY-3'HYDROXYMETHYLPHENYL) -ETHANOL (1)
EP0120165A2 (en) * 1982-12-10 1984-10-03 Greenway III, Frank L. A preparation and a process for achieving regional weight control
EP0120165A3 (en) * 1982-12-10 1985-06-19 Frank L. Greenway Iii A preparation and a process for achieving regional weight control
US4751071A (en) * 1983-12-01 1988-06-14 Alza Corporation Composition comprising salbutamol
US4777049A (en) * 1983-12-01 1988-10-11 Alza Corporation Constant release system with pulsed release
US4851229A (en) * 1983-12-01 1989-07-25 Alza Corporation Composition comprising a therapeutic agent and a modulating agent

Also Published As

Publication number Publication date
IE38655L (en) 1974-06-15
IL43820A (en) 1977-08-31
DE2362123A1 (en) 1974-06-20
ZA739480B (en) 1975-08-27
BE808662A (en) 1974-06-14
IL43820A0 (en) 1974-03-14
AU6364773A (en) 1975-06-19
IE38655B1 (en) 1978-05-10

Similar Documents

Publication Publication Date Title
FI945621A0 (en) Regulated release formulation
GB2254784B (en) Film-coated solid dosage form of anti-migraine drug
TR200000229T2 (en) Substituted 1,2,3,4-Tetrahydronaphthalene derivative i
RU94022479A (en) Use of antiestrogenic compounds and pharmaceutically acceptable salts and solvents for blood glucose concentration decrease, pharmaceutical preparation
PT95117A (en) METHOD FOR THE TREATMENT OF EARLY EJACULATION USING SERTRALINE
SE9401728D0 (en) New compounds II
GB1453034A (en) Pharmaceutical composition for treating spasticity
RU93032613A (en) PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF PATIENTS WITH PROLONGED COAGULATION TIME, METHOD OF TREATING PATIENTS, USING THE EPI INHIBITOR FOR OBTAINING THE PHARMACEUTICAL PREPARATION
KR900014406A (en) Cefem compound and preparation method thereof
BG60101B2 (en) Method for preparing of 4-fluoro-2-[[(4-methoxy-2-pyridinyl)methyl]thionil]-1h-benzimidazo le
GB9108629D0 (en) Heterocyclic pharmaceutical compounds,preparation and use
GB1487334A (en) Pharmaceutical preparations comprising lisuride and/or physiologically tolerable salts thereof
DK211489A (en) PHARMACEUTICAL PREPARATION
TR200103144T2 (en) New compounds
TR199801184T2 (en) New compounds with analgesic action.
BR0011880A (en) Method for the treatment of co-morbid conditions associated with obesity, compound, product, use of a compound, and pharmaceutical composition
DE69910600D1 (en) USE OF METFORMIN AGAINST THE WEIGHT GAIN RELATED TO VALPROAT AND OTHER PSYCHOTROPIC MEDICINAL PRODUCTS
KR930702985A (en) Treatment of Esophageal Cancer
HK1013622A1 (en) Pharmaceutical lysine-containing polypeptide compositions and the use thereof
DE59205998D1 (en) Medicament with antineoplastic activity containing octadecyl- [2- (N-methylpiperidino) ethyl] phosphate as active ingredient and process for its preparation
GB1420976A (en) Pharmaceutical compositions for use in the treatment of certain respiratory diseases or conditions in prematurely born children
GB2019720A (en) S-adenosyl-L-homocysteine and salts thereof for use in therapy
MX9701528A (en) 1,1,2-triphenylbut-1-ene derivatives for treating alzheimers disease.
IT1271354B (en) Preparation of a pharmaceutical form capable of combating hyperinsulinism

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee